BioMarin to buy Prosensa in $840 million deal

lundi 24 novembre 2014

To match ANALYSIS BIOTECHNOLOGY-EUROPE/ BioMarin Pharmaceuticals Inc said it would buy Dutch drug developer Prosensa Holding NV for about $840 million including milestone payments, aiming to add to its portfolio of drugs to treat rare diseases. ...








via Business News http://ift.tt/1r0DFU2

0 commentaires:

Enregistrer un commentaire